Page last updated: 2024-08-26

fibrinogen and Castleman Disease

fibrinogen has been researched along with Castleman Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appiani, C; Fajgenbaum, DC; Guilfoyle, M; Morra, DE; Nemat, S; Pierson, SK; Shilling, D; Tendler, C; van Rhee, F1
Bauters, A; Copin, MC; Hachulla, E; Rogosnitzky, M; Saudemont, A; Zerbib, P1
Kishimoto, T; Matsumoto, T; Nakagawa, M; Nishimoto, N; Sasai, M; Shima, Y; Shirai, T; Yoshizaki, K1

Trials

2 trial(s) available for fibrinogen and Castleman Disease

ArticleYear
Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data.
    British journal of haematology, 2019, Volume: 184, Issue:2

    Topics: Adult; Antibodies, Monoclonal; C-Reactive Protein; Castleman Disease; Female; Fibrinogen; Humans; Immunoglobulin A; Immunoglobulin G; Interleukin-6; Male; Middle Aged; Models, Biological; Predictive Value of Tests

2019
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.
    Blood, 2000, Jan-01, Volume: 95, Issue:1

    Topics: Adult; Amyloidosis; Anemia; Antibodies, Monoclonal; C-Reactive Protein; Castleman Disease; Fatigue; Female; Fibrinogen; Humans; Interleukin-6; Male; Middle Aged; Receptors, Interleukin-6; Serum Albumin; Time Factors

2000

Other Studies

1 other study(ies) available for fibrinogen and Castleman Disease

ArticleYear
Elevated plasma fibrinogen in clinically asymptomatic unicentric Castleman's disease: a case report.
    Journal of clinical and experimental hematopathology : JCEH, 2014, Volume: 54, Issue:1

    Topics: Asymptomatic Diseases; Castleman Disease; Female; Fibrinogen; Humans; Incidental Findings; Magnetic Resonance Imaging; Middle Aged; Omentum; Radiography, Abdominal; Tomography, X-Ray Computed; Treatment Outcome

2014